Logo image of HYLN

HYLIION HOLDINGS CORP (HYLN) Stock Fundamental Analysis

USA - NYSEARCA:HYLN - US4491091074 - Common Stock

2.11 USD
+0.09 (+4.46%)
Last: 10/3/2025, 8:04:00 PM
2.0802 USD
-0.03 (-1.41%)
After Hours: 10/3/2025, 8:04:00 PM
Fundamental Rating

4

Overall HYLN gets a fundamental rating of 4 out of 10. We evaluated HYLN against 93 industry peers in the Electrical Equipment industry. HYLN has a great financial health rating, but its profitability evaluates not so good. HYLN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

HYLN had negative earnings in the past year.
In the past year HYLN has reported a negative cash flow from operations.
HYLN had negative earnings in 4 of the past 5 years.
In the past 5 years HYLN always reported negative operating cash flow.
HYLN Yearly Net Income VS EBIT VS OCF VS FCFHYLN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

HYLN's Return On Assets of -24.55% is in line compared to the rest of the industry. HYLN outperforms 43.01% of its industry peers.
HYLN's Return On Equity of -26.07% is in line compared to the rest of the industry. HYLN outperforms 58.06% of its industry peers.
Industry RankSector Rank
ROA -24.55%
ROE -26.07%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HYLN Yearly ROA, ROE, ROICHYLN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

HYLN has a worse Gross Margin (6.75%) than 76.34% of its industry peers.
The Profit Margin and Operating Margin are not available for HYLN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HYLN Yearly Profit, Operating, Gross MarginsHYLN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K -40K

8

2. Health

2.1 Basic Checks

HYLN does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for HYLN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HYLN Yearly Shares OutstandingHYLN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 50M 100M 150M
HYLN Yearly Total Debt VS Total AssetsHYLN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

HYLN has an Altman-Z score of 15.15. This indicates that HYLN is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of HYLN (15.15) is better than 93.55% of its industry peers.
There is no outstanding debt for HYLN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 15.15
ROIC/WACCN/A
WACC8.77%
HYLN Yearly LT Debt VS Equity VS FCFHYLN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

HYLN has a Current Ratio of 11.16. This indicates that HYLN is financially healthy and has no problem in meeting its short term obligations.
HYLN's Current ratio of 11.16 is amongst the best of the industry. HYLN outperforms 95.70% of its industry peers.
A Quick Ratio of 11.16 indicates that HYLN has no problem at all paying its short term obligations.
The Quick ratio of HYLN (11.16) is better than 95.70% of its industry peers.
Industry RankSector Rank
Current Ratio 11.16
Quick Ratio 11.16
HYLN Yearly Current Assets VS Current LiabilitesHYLN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 200M 400M 600M

6

3. Growth

3.1 Past

HYLN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.95%, which is quite good.
HYLN shows a strong growth in Revenue. In the last year, the Revenue has grown by 3413.00%.
The Revenue has been growing by 96.13% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)17.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)3413%
Revenue growth 3Y96.13%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to decrease by -8.70% on average over the next years.
Based on estimates for the next years, HYLN will show a very strong growth in Revenue. The Revenue will grow by 392.73% on average per year.
EPS Next Y-28.44%
EPS Next 2Y-14.99%
EPS Next 3Y-8.7%
EPS Next 5YN/A
Revenue Next Year1050.78%
Revenue Next 2Y589.2%
Revenue Next 3Y392.73%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HYLN Yearly Revenue VS EstimatesHYLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
HYLN Yearly EPS VS EstimatesHYLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1

0

4. Valuation

4.1 Price/Earnings Ratio

HYLN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year HYLN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HYLN Price Earnings VS Forward Price EarningsHYLN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HYLN Per share dataHYLN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

A cheap valuation may be justified as HYLN's earnings are expected to decrease with -8.70% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-14.99%
EPS Next 3Y-8.7%

0

5. Dividend

5.1 Amount

No dividends for HYLN!.
Industry RankSector Rank
Dividend Yield N/A

HYLIION HOLDINGS CORP

NYSEARCA:HYLN (10/3/2025, 8:04:00 PM)

After market: 2.0802 -0.03 (-1.41%)

2.11

+0.09 (+4.46%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)11-12 2025-11-12/amc
Inst Owners28.03%
Inst Owner Change0%
Ins Owners26.95%
Ins Owner Change0.08%
Market Cap370.18M
Analysts43.33
Price Target2.86 (35.55%)
Short Float %13.7%
Short Ratio15.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.85%
Min EPS beat(2)-22.55%
Max EPS beat(2)12.85%
EPS beat(4)2
Avg EPS beat(4)13.17%
Min EPS beat(4)-22.55%
Max EPS beat(4)74.42%
EPS beat(8)6
Avg EPS beat(8)26.58%
EPS beat(12)8
Avg EPS beat(12)15.33%
EPS beat(16)12
Avg EPS beat(16)17.28%
Revenue beat(2)0
Avg Revenue beat(2)-31.79%
Min Revenue beat(2)-56.42%
Max Revenue beat(2)-7.17%
Revenue beat(4)1
Avg Revenue beat(4)8.07%
Min Revenue beat(4)-100%
Max Revenue beat(4)195.88%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-14.29%
EPS NY rev (1m)0%
EPS NY rev (3m)-13.33%
Revenue NQ rev (1m)-30%
Revenue NQ rev (3m)-30%
Revenue NY rev (1m)-42.46%
Revenue NY rev (3m)-53.78%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 105.37
P/FCF N/A
P/OCF N/A
P/B 1.71
P/tB 1.71
EV/EBITDA N/A
EPS(TTM)-0.32
EYN/A
EPS(NY)-0.36
Fwd EYN/A
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS0.02
BVpS1.23
TBVpS1.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.55%
ROE -26.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.75%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 467.27%
Cap/Sales 570.62%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.16
Quick Ratio 11.16
Altman-Z 15.15
F-Score4
WACC8.77%
ROIC/WACCN/A
Cap/Depr(3y)323.62%
Cap/Depr(5y)255.56%
Cap/Sales(3y)777.8%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
EPS Next Y-28.44%
EPS Next 2Y-14.99%
EPS Next 3Y-8.7%
EPS Next 5YN/A
Revenue 1Y (TTM)3413%
Revenue growth 3Y96.13%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year1050.78%
Revenue Next 2Y589.2%
Revenue Next 3Y392.73%
Revenue Next 5YN/A
EBIT growth 1Y20.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year7.4%
EBIT Next 3Y6.21%
EBIT Next 5YN/A
FCF growth 1Y48.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.1%
OCF growth 3YN/A
OCF growth 5YN/A